ETrade Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

ETrade Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.21M	Buy	8,541 +1,287	+18%	+$215K	0.02%	325
2020 Q2	$1.43M	Buy	7,254 +5,184	+250%	+$1.07M	0.03%	263
2020 Q1	$406K	Sell	2,070 -381	-16%	-$82K	0.01%	521
2019 Q4	$507K	Buy	2,451 +21	+0.9%	+$3.88K	0.01%	550
2019 Q3	$371K	Buy	+2,430	New	+$398K	0.01%	624

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

ETrade Capital Management's LKFT Position: Q3 2020 in Review

ETrade Capital Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 18% in Q3 2020, buying an estimated $215K and bringing the position to 8,541 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #325.

ETrade Capital Management first reported a position in LKFT in Q3 2019 and has held it in 5 quarters since. The position peaked at $1.43M in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

ETrade Capital Management held 8,541 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.21M as of Q3 2020.
ETrade Capital Management bought 1,287 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $215K.
Lakefront Biotherapeutics American Depositary Shares made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #325 holding.
ETrade Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 5 quarters since.
ETrade Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.43M in Q2 2020.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.